Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology.
BACKGROUND
Spurious increases in serum troponins, especially troponin T, have been reported in patients with and without acute myocardial syndromes.


METHODS
We studied 78 autopsied patients without clinical myocardial infarction (MI) and correlated histologic cardiac findings with antemortem serum creatine kinase (CK), its MB isoenzyme (CK-MB), cardiac troponin I (cTnI), and cardiac troponin T (cTnT).


RESULTS
There was no significant myocardial pathology in 15 patients. Cardiac pathologies were in five groups: scarring from previous MI or patchy ventricular fibrosis (n = 9), recent MI (n = 27), healing MI (n = 7), degenerative myocyte changes consistent with congestive heart failure (CHF; n = 12), and other cardiac pathologies (n = 8). The median concentrations in the five groups were not significantly different for either CK or CK-MB. Compared with the no-pathology group, only the MI group was significantly different for cTnI, and the MI and other pathology groups were significantly different for cTnT. For patients with MI, 22%, 19%, 48%, and 65% had increased CK, CK-MB, cTnI, and cTnT, respectively; for CHF and other cardiac pathologies combined, the percentages were 28%, 17%, 22%, and 50%. For patients with increased cTnI, 72% and 28% had MI and other myocardial pathologies, respectively; patients with increased cTnT had 64% and 36%, respectively. Patients without myocardial pathology had no increases in CK-MB, cTnI, or cTnT.


CONCLUSIONS
All patients with increased serum CK-MB, cTnI, and cTnT had significant cardiac histologic changes. The second-generation cTnT assay appears to be a more sensitive indicator of MI and other myocardial pathologies than the cTnI assay used in this study.
Ooi
D S
DS
Department of Pathology and Laboratory Medicine, Ottawa Hospital-Civic Campus, Ottawa, ON K1Y 4E9 Canada. dsooi@ottawahospital.on.ca
Isotalo
P A
PA
Veinot
J P
JP
D001344:Autopsy; D003402:Creatine Kinase / Q000097:blood*; D005260:Female; D005355:Fibrosis; D006331:Heart Diseases / Q000097:blood / Q000201:enzymology / Q000473:pathology*; D006333:Heart Failure / Q000097:blood / Q000201:enzymology / Q000473:pathology; D006801:Humans; D007527:Isoenzymes; D008297:Male; D009203:Myocardial Infarction / Q000097:blood / Q000201:enzymology / Q000473:pathology; D009206:Myocardium / Q000473:pathology; D012680:Sensitivity and Specificity; D019210:Troponin I / Q000097:blood*; D020107:Troponin T / Q000097:blood*
D007527:Isoenzymes; D019210:Troponin I; D020107:Troponin T; D003402:Creatine Kinase